FDx Advisors’s iShares Biotechnology ETF IBB Stock Holding History

FDx Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,939	Closed	-$323K	–	913
2018 Q2	$323K	Buy	+2,939	New	+$314K	0.01%	699
2018 Q1	–	Sell	-2,495	Closed	-$266K	–	1206
2017 Q4	$266K	Sell	2,495 -1,753	-41%	-$187K	0.01%	1091
2017 Q3	$472K	Buy	4,248 +1,413	+50%	+$151K	0.01%	825
2017 Q2	$293K	Sell	2,835 -2,463	-46%	-$243K	0.01%	991
2017 Q1	$518K	Buy	5,298 +819	+18%	+$78.4K	0.02%	766
2016 Q4	$396K	Buy	+4,479	New	+$408K	0.01%	853

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

FDx Advisors's IBB Position: Q3 2018 in Review

FDx Advisors sold out of iShares Biotechnology ETF (IBB) in Q3 2018, closing a stake of 2,939 shares — an estimated $323K sold.

FDx Advisors first reported a position in IBB in Q4 2016 and held it in 6 quarters. The position peaked at $518K in Q1 2017. 631 funds tracked by Wall St. Rank hold IBB as of Q3 2018.

FDx Advisors reported no remaining iShares Biotechnology ETF position as of Q3 2018 after selling out during the quarter.
FDx Advisors sold 2,939 iShares Biotechnology ETF shares in Q3 2018, an estimated $323K.
FDx Advisors first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 6 quarters.
FDx Advisors's iShares Biotechnology ETF position peaked at $518K in Q1 2017.
631 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2018.

Based on FDx Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.